World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
57
Citations
12844
World Ranking
13745
National Ranking
5821

Ernesto Guccione publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Ernesto Guccione sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 243 publications — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Ernesto Guccione D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Ernesto Guccione sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 57 D-Index — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Ernesto Guccione is affiliated with the Icahn School of Medicine at Mount Sinai in the United States. Their research spans multiple areas within biochemistry, genetics, molecular biology, and medicine, with a particular focus on molecular biology and cancer research. The scientist's work also touches on infectious diseases and pulmonary and respiratory medicine.

The main fields of study for Ernesto Guccione include:

  • Biochemistry, Genetics and Molecular Biology
  • Medicine

Within these domains, their subfields of study emphasize:

  • Molecular Biology
  • Cancer Research
  • Oncology
  • Infectious Diseases
  • Pulmonary and Respiratory Medicine

The primary topics covered in their research are:

  • RNA modifications and cancer
  • Cancer-related gene regulation
  • RNA Research and Splicing
  • Epigenetics and DNA Methylation
  • Ubiquitin and proteasome pathways
  • SARS-CoV-2 and COVID-19 Research
  • Protein Degradation and Inhibitors

Ernesto Guccione has contributed to numerous scientific publications. Frequent venues where their work appears include:

  • Nature Communications
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cancer Research
  • Journal of Hepatology
  • Cell

Notable recent papers authored or co-authored by Ernesto Guccione comprise:

  • "Epigenetic Silencing of CDR1as Drives IGF2BP3-Mediated Melanoma Invasion and Metastasis" (2020, Cancer Cell)
  • "Trained Immunity-Promoting Nanobiologic Therapy Suppresses Tumor Growth and Potentiates Checkpoint Inhibition" (2020, Cell)
  • "Novel microenvironment-based classification of intrahepatic cholangiocarcinoma with therapeutic implications" (2022, Gut)
  • "Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naive and COVID-19 recovered individuals" (2021, Cell Reports)
  • "TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation" (2021, Cell)

Collaborations have been frequent with several researchers, including:

  • Alexander Rialdi
  • Tommaso Tabaglio
  • Megan Schwarz
  • Slim Mzoughi
  • Josep M. Llovet

Best Publications

  • The Histone Deacetylase SIRT6 Is a Tumor Suppressor that Controls Cancer Metabolism

    Carlos Sebastián;Bernardette M. M. Zwaans;Dafne Magali Silberman;Dafne Magali Silberman;Melissa Gymrek

  • Methylation of histone H3R2 by PRMT6 and H3K4 by an MLL complex are mutually exclusive.

    Ernesto Guccione;Christian Bassi;Fabio Casadio;Francesca Martinato

  • Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis

    Arianna Sabò;Arianna Sabò;Theresia R. Kress;Theresia R. Kress;Mattia Pelizzola;Stefano de Pretis

  • The regulation, functions and clinical relevance of arginine methylation.

    Ernesto Guccione;Stéphane Richard

  • Myc-binding-site recognition in the human genome is determined by chromatin context

    Ernesto Guccione;Francesca Martinato;Giacomo Finocchiaro;Lucilla Luzi

  • MYC regulates the core pre-mRNA splicing machinery as an essential step in lymphomagenesis

    Cheryl M. Koh;Marco Bezzi;Diana H P Low;Wei X ia Ang

  • Symmetric dimethylation of H3R2 is a newly identified histone mark that supports euchromatin maintenance

    Valentina Migliori;Julius Müller;Sameer Phalke;Diana Low

  • Chromatin and Transcription Transitions of Mammalian Adult Germline Stem Cells and Spermatogenesis

    Saher Sue Hammoud;Diana H.P. Low;Diana H.P. Low;Chongil Yi;Douglas T. Carrell

  • Regulation of constitutive and alternative splicing by PRMT5 reveals a role for Mdm4 pre-mRNA in sensing defects in the spliceosomal machinery

    Marco Bezzi;Shun Xie Teo;Julius Muller;Wei Chuen Mok

  • Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation.

    Miranda Thomas;Richard Laura;Karin Hepner;Ernesto Guccione

  • Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia.

    Anna Migliazza;Francesc Bosch;Francesc Bosch;Francesc Bosch;Hirokazu Komatsu;Hirokazu Komatsu;Hirokazu Komatsu;Eftihia Cayanis;Eftihia Cayanis;Eftihia Cayanis

  • Epigenetic Silencing of CDR1as Drives IGF2BP3-Mediated Melanoma Invasion and Metastasis.

    Douglas Hanniford;Alejandro Ulloa-Morales;Alcida Karz;Maria Gabriela Berzoti-Coelho;Maria Gabriela Berzoti-Coelho

  • Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation.

    Jia Yi Fong;Jia Yi Fong;Luca Pignata;Luca Pignata;Pierre-Alexis Goy;Pierre-Alexis Goy;Kimihito Cojin Kawabata

  • PTBP1-Mediated Alternative Splicing Regulates the Inflammatory Secretome and the Pro-tumorigenic Effects of Senescent Cells.

    Athena Georgilis;Sabrina Klotz;Christopher J. Hanley;Nicolas Herranz

  • Trained immunity in newborn infants of HBV-infected mothers

    Michelle Hong;Elena Sandalova;Diana Low;Adam J. Gehring

  • The Ankrd2 Protein, a Link Between the Sarcomere and the Nucleus in Skeletal Muscle

    Snezana Kojic;Elisa Medeot;Ernesto Guccione;Helena Krmac

  • PRMT5 Is a Critical Regulator of Breast Cancer Stem Cell Function via Histone Methylation and FOXP1 Expression

    Kelly Chiang;Agnieszka E. Zielinska;Abeer M. Shaaban;Maria Pilar Sanchez-Bailon

  • Discovery of a first-in-class EZH2 selective degrader.

    Anqi Ma;Elias Stratikopoulos;Kwang-Su Park;Jieli Wei

  • Single-Cell Profiling of Epigenetic Modifiers Identifies PRDM14 as an Inducer of Cell Fate in the Mammalian Embryo

    Adam Burton;Julius Muller;Shengjiang Tu;Pablo Padilla-Longoria

  • Antisense oligonucleotide-mediated MDM4 exon 6 skipping impairs tumor growth.

    Michael Dewaele;Tommaso Tabaglio;Tommaso Tabaglio;Karen Willekens;Marco Bezzi;Marco Bezzi

Frequent Co-Authors

Bruno Amati
Bruno Amati European Institute of Oncology
Antonio Bertoletti
Antonio Bertoletti Duke NUS Graduate Medical School
Philipp Kaldis
Philipp Kaldis Lund University
Lawrence Banks
Lawrence Banks International Centre for Genetic Engineering and Biotechnology
Reshma Taneja
Reshma Taneja National University of Singapore
Vinay Tergaonkar
Vinay Tergaonkar Agency for Science, Technology and Research
Jian Jin
Jian Jin Icahn School of Medicine at Mount Sinai
Masoud Vedadi
Masoud Vedadi Structural Genomics Consortium
Cheryl H. Arrowsmith
Cheryl H. Arrowsmith Structural Genomics Consortium
Matthew T. Weirauch
Matthew T. Weirauch Cincinnati Children's Hospital Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Ernesto Guccione

Trending Scientists

Recently Published Articles